Aridis pharmaceuticals ceo to participate in a fireside chat presented by maxim group llc and hosted by m-vest on june 7

Los gatos, calif. , june 3, 2022 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that vu truong, ph.d.
ARDS Ratings Summary
ARDS Quant Ranking